Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy

被引：84

作者：

Cook, Gordon ^{[1
,2
]}

John Ashcroft, A. ^{[3
]}

Pratt, Guy ^{[4
]}

Popat, Rakesh ^{[5
]}

Ramasamy, Karthik ^{[6
]}

Kaiser, Martin ^{[7
]}

Jenner, Matthew ^{[8
]}

Henshaw, Sarah ^{[9
]}

Hall, Rachel ^{[10
]}

Sive, Jonathan ^{[5
]}

Stern, Simon ^{[11
]}

Streetly, Matthew ^{[12
]}

Bygrave, Ceri ^{[13
]}

Soutar, Richard ^{[14
]}

Rabin, Neil ^{[5
]}

Jackson, Graham H. ^{[15
]}

机构：

[1] Univ Leeds, Leeds Inst Clin Trial Res, Leeds, W Yorkshire, England

[2] Univ Leeds, Leeds Canc Ctr, Leeds, W Yorkshire, England

[3] Mid Yorkshire NHS Trust, Pinderfields Hosp, Dept Haematol, Wakefield, England

[4] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England

[5] Univ Coll London Hosp NHS Fdn Trust, Dept Haematol, London, England

[6] Oxford Univ Hosp NHS FT, NIHR BRC Blood Theme, Oxford, England

[7] Inst Canc Res, London, England

[8] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England

[9] Nottingham City Hosp, Dept Haematol, Nottingham, England

[10] Royal Bournemouth & Christchurch Hosp NHS Fdn Tru, Bournemouth, Dorset, England

[11] Epsom & St Helier Univ Hosp NHS Trust, Dept Haematol, Carshalton, Surrey, England

[12] Guys & St Thomass Trust, Dept Haematol, London, England

[13] Univ Hosp Wales, Dept Haematol, Cardiff, Wales

[14] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland

[15] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 190卷 / 02期

关键词：

COVID-19; multiple myeloma; systemic antic-cancer therapy;

D O I：

10.1111/bjh.16874

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E83 / E86

页数：4

共 14 条

[1] Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma
Binder, Moritz
Rajkumar, S. Vincent
Lacy, Martha Q.
Gertz, Morie A.
Buadi, Francis K.
Dispenzieri, Angela
Hwa, Yi L.
Fonder, Amie
Hobbs, Miriam
Hayman, Suzanne R.
Zeldenrust, Steven R.
Lust, John A.
Russell, Stephen J.
Leung, Nelson
Kapoor, Prashant
Go, Ronald S.
Gonsalves, Wilson I.
Kourelis, Taxiarchis
Warsame, Rahma
Kyle, Robert A.
Kumar, Shaji K.
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (03) : 306 - 311
[2] Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd
Chari, Ajai
Richardson, Paul G.
Romanus, Dorothy
Dimopoulos, Meletios A.
Sonneveld, Pieter
Terpos, Evangelos
Hajek, Roman
Raju, Aditya
Palumbo, Antonio
Cain, Lauren E.
Blazer, Marlo
Huang, Hui
Farrelly, Eileen
Ailawadhi, Sikander
[J]. EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (04) : 421 - 433
[3] Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States
Costa, Luciano J.
Brill, Ilene K.
Omel, James
Godby, Kelly
Kumar, Shaji K.
Brown, Elizabeth E.
[J]. BLOOD ADVANCES, 2017, 1 (04) : 282 - 287
[4] Global Burden of Multiple Myeloma ASystematic Analysis for the Global Burden of Disease Study 2016
Cowan, Andrew J.
Allen, Christine
Barac, Aleksandra
Basaleem, Huda
Bensenor, Isabela
Curado, Maria Paula
Foreman, Kyle
Gupta, Rahul
Harvey, James
Hosgood, H. Dean
Jakovljevic, Mihajlo
Khader, Yousef
Linn, Shai
Lad, Deepesh
Mantovani, Lorenzo
Vuong Minh Nong
Mokdad, Ali
Naghavi, Mohsen
Postma, Maarten
Roshandel, Gholamreza
Shackelford, Katya
Sisay, Mekonnen
Cuong Tat Nguyen
Tung Thanh Tran
Bach Tran Xuan
Ukwaja, Kingsley Nnanna
Vollset, Stein Emil
Weiderpass, Elisabete
Libby, Edward N.
Fitzmaurice, Christina
[J]. JAMA ONCOLOGY, 2018, 4 (09) : 1221 - 1227
[5] Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
Drayson, Mark T.
Bowcock, Stella
Planche, Tim
Iqbal, Gulnaz
Pratt, Guy
Yong, Kwee
Wood, Jill
Raynes, Kerry
Higgins, Helen
Dawkins, Bryony
Meads, David
Hulme, Claire T.
Monahan, Irene
Karunanithi, Kamaraj
Dignum, Helen
Belsham, Edward
Neilson, Jeff
Harrison, Beth
Lokare, Anand
Campbell, Gavin
Hamblin, Michael
Hawkey, Peter
Whittaker, Anna C.
Low, Eric
Dunn, Janet A.
[J]. LANCET ONCOLOGY, 2019, 20 (12) : 1760 - 1772
[6] Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism
Fernando, Rodrigo Carlini
Mazzotti, Diego Robles
Azevedo, Hatylas
Sandes, Alex Freire
Rizzatti, Edgar Gil
de Oliveira, Mariana Bleker
Alves, Veruska Lia Fook
Pereira Eugenio, Angela Isabel
de Carvalho, Fabricio
Dalboni, Maria Aparecida
Martins, David Correa
Braga Colleoni, Gisele Wally
[J]. SCIENTIFIC REPORTS, 2019, 9 (1)
[7] Huang CL, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30211-7, 10.1016/S0140-6736(20)30183-5]
[8] Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020
Kinross, Pete
Suetens, Carl
Dias, Joana Gomes
Alexakis, Leonidas
Wijermans, Ariana
Colzani, Edoardo
Monnet, Dominique L.
[J]. EUROSURVEILLANCE, 2020, 25 (11) : 2 - 6
[9] Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
Landgren, Ola
Hofmann, Jonathan N.
McShane, Charlene M.
Santo, Loredana
Hultcrantz, Malin
Korde, Neha
Mailankody, Sham
Kazandjian, Dickran
Murata, Kazunori
Thoren, Katie
Ramanathan, Lakshmi
Dogan, Ahmet
Rustad, Even
Lu, Sydney X.
Akhlaghi, Theresia
Kristinsson, Sigurdur Y.
Bjorkholm, Magnus
Devlin, Sean
Purdue, Mark P.
Pfeiffer, Ruth M.
Turesson, Ingemar
[J]. JAMA ONCOLOGY, 2019, 5 (09) : 1293 - 1301
[10] Community-acquired respiratory infections are common in patients with non-Hodgkin lymphoma and multiple myeloma
Lavi, Noa
Avivi, Irit
Kra-Oz, Zipora
Oren, Ilana
Hardak, Emilia
[J]. SUPPORTIVE CARE IN CANCER, 2018, 26 (07) : 2425 - 2431

← 1 2 →